An in-silico approach has been adopted to construct a multi-epitope vaccine from selected immunogenic extracellular vesicle proteins to elicit a cellular as well as a humoral immune response.
[Scientific Reports]
6445218
{6445218:YCW5H3WU}
apa
50
1
164218
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-ec9c35e09481916a83cdaec20a4f4403%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22YCW5H3WU%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sharma%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESharma%2C%20R.%2C%20Rajput%2C%20V.%20S.%2C%20Jamal%2C%20S.%2C%20Grover%2C%20A.%2C%20%26amp%3B%20Grover%2C%20S.%20%282021%29.%20An%20immunoinformatics%20approach%20to%20design%20a%20multi-epitope%20vaccine%20against%20Mycobacterium%20tuberculosis%20exploiting%20secreted%20exosome%20proteins.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%2013836.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-93266-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-93266-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DYCW5H3WU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20immunoinformatics%20approach%20to%20design%20a%20multi-epitope%20vaccine%20against%20Mycobacterium%20tuberculosis%20exploiting%20secreted%20exosome%20proteins%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vikrant%20Singh%22%2C%22lastName%22%3A%22Rajput%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salma%22%2C%22lastName%22%3A%22Jamal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhinav%22%2C%22lastName%22%3A%22Grover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonam%22%2C%22lastName%22%3A%22Grover%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20is%20one%20the%20oldest%20known%20affliction%20of%20mankind%20caused%20by%20the%20pathogen%20Mycobacterium%20tuberculosis.%20Till%20date%2C%20there%20is%20no%20absolute%20single%20treatment%20available%20to%20deal%20with%20the%20pathogen%2C%20which%20has%20acquired%20a%20great%20potential%20to%20develop%20drug%20resistance%20rapidly.%20BCG%20is%20the%20only%20anti-tuberculosis%20vaccine%20available%20till%20date%20which%20displays%20limited%20global%20efficacy%20due%20to%20genetic%20variation%20and%20concurrent%20pathogen%20infections.%20Extracellular%20vesicles%20or%20exosomes%20vesicle%20%28EVs%29%20lie%20at%20the%20frontier%20cellular%20talk%20between%20pathogen%20and%20the%20host%2C%20and%20therefore%20play%20a%20significant%20role%20in%20establishing%20pathogenesis.%20In%20the%20present%20study%2C%20an%20in-silico%20approach%20has%20been%20adopted%20to%20construct%20a%20multi-epitope%20vaccine%20from%20selected%20immunogenic%20EVs%20proteins%20to%20elicit%20a%20cellular%20as%20well%20as%20a%20humoral%20immune%20response.%20Our%20designed%20vaccine%20has%20wide%20population%20coverage%20and%20can%20effectively%20compensate%20for%20the%20genetic%20variation%20among%20different%20populations.%20For%20maximum%20efficacy%20and%20minimum%20adverse%20effects%20possibilities%20the%20antigenic%2C%20non-allergenic%20and%20non-toxic%20B-cell%2C%20HTL%20and%20CTL%20epitopes%20from%20experimentally%20proven%20EVs%20proteins%20were%20selected%20for%20the%20vaccine%20construct.%20TLR4%20agonist%20RpfE%20served%20as%20an%20adjuvant%20for%20the%20vaccine%20construct.%20The%20vaccine%20construct%20structure%20was%20modelled%2C%20refined%20and%20docked%20on%20TLR4%20immune%20receptor.%20The%20designed%20vaccine%20construct%20displayed%20safe%20usage%20and%20exhibits%20a%20high%20probability%20to%20elicit%20the%20critical%20immune%20regulators%2C%20like%20B%20cells%2C%20T-cells%20and%20memory%20cells%20as%20displayed%20by%20the%20in-silico%20immunization%20assays.%20Therefore%2C%20it%20can%20be%20further%20corroborated%20using%20in%20vitro%20and%20in%20vivo%20assays%20to%20fulfil%20the%20global%20need%20for%20a%20more%20efficacious%20anti-tuberculosis%20vaccine.%22%2C%22date%22%3A%222021-07-05%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-93266-w%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41598-021-93266-w%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-05T21%3A30%3A43Z%22%7D%7D%5D%7D
Sharma, R., Rajput, V. S., Jamal, S., Grover, A., & Grover, S. (2021). An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins. Scientific Reports, 11(1), 13836. https://doi.org/10.1038/s41598-021-93266-w Cite
